Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Lopez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Molecular Biology|May 5, 2015
The Mechanism and Function of Group II ChaperoninsTom Lopez, Kevin Dalton, Judith Frydman
Scientific Reports|February 12, 2020
REP-X: An Evolution-guided Strategy for the Rational Design of Cysteine-less Protein VariantsKevin Dalton, Tom Lopez, Vijay Pande, et al.
Nature Structural & Molecular Biology|July 26, 2017
An information theoretic framework reveals a tunable allosteric network in group II chaperoninsTom Lopez, Kevin Dalton, Anthony Tomlinson, et al.
The EMBO Journal|December 24, 2011
Mechanism of nucleotide sensing in group II chaperoninsJose H Pereira, Corie Y Ralston, Nicholai R Douglas, et al.
Elife|June 7, 2024
Targeted protein degradation systems to enhance Wnt signalingParthasarathy Sampathkumar, Heekyung Jung, Hui Chen, et al.
Translational Vision Science & Technology|September 23, 2022
SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic RetinopathyHuy Nguyen, Hui Chen, Meghah Vuppalapaty, et al.
Translational Vision Science & Technology|June 10, 2025
WNT Mimetic-Induced Lacrimal Gland Regeneration Reverses Aqueous Tear DeficiencyHuy Nguyen, Russell B Fletcher, Tom Lopez, et al.
Cell Chemical Biology|July 6, 2023
Novel Frizzled-specific antibody-based Wnt mimetics and Wnt superagonists selectively activate WNT/β-catenin signaling in target tissuesYorick Post, Archana Dilip, Liqin Xie, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Molecular Biology|May 5, 2015
The Mechanism and Function of Group II ChaperoninsTom Lopez, Kevin Dalton, Judith Frydman
Scientific Reports|February 12, 2020
REP-X: An Evolution-guided Strategy for the Rational Design of Cysteine-less Protein VariantsKevin Dalton, Tom Lopez, Vijay Pande, et al.
Nature Structural & Molecular Biology|July 26, 2017
An information theoretic framework reveals a tunable allosteric network in group II chaperoninsTom Lopez, Kevin Dalton, Anthony Tomlinson, et al.
The EMBO Journal|December 24, 2011
Mechanism of nucleotide sensing in group II chaperoninsJose H Pereira, Corie Y Ralston, Nicholai R Douglas, et al.
Elife|June 7, 2024
Targeted protein degradation systems to enhance Wnt signalingParthasarathy Sampathkumar, Heekyung Jung, Hui Chen, et al.
Translational Vision Science & Technology|September 23, 2022
SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic RetinopathyHuy Nguyen, Hui Chen, Meghah Vuppalapaty, et al.
Translational Vision Science & Technology|June 10, 2025
WNT Mimetic-Induced Lacrimal Gland Regeneration Reverses Aqueous Tear DeficiencyHuy Nguyen, Russell B Fletcher, Tom Lopez, et al.
Cell Chemical Biology|July 6, 2023
Novel Frizzled-specific antibody-based Wnt mimetics and Wnt superagonists selectively activate WNT/β-catenin signaling in target tissuesYorick Post, Archana Dilip, Liqin Xie, et al.
Pageof 1